• 1
    Srinivas TR, Schold JD, Guerra, G, Eagan, A, Bucci CM, Meier-Kriesche HU. Mycophenolate mofetil/sirolimus compared to other common immunosuppressive regimens in kidney transplantation. Am J Transplant 2007; 7: 586594.
  • 2
    Srinivas TR, Meier-Kriesche HU. Minimizing immunosuppression, an alternative approach to reducing side effects: Objectives and interim result. Clin J Am Soc Nephrol 2008; 3(Suppl 2): S101S116.
  • 3
    Pascual, M, Theruvath, T, Kawai, T, Tolkoff-Rubin, N, Cosimi AB. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002; 346: 580590.
  • 4
    Yang, H. Maintenance immunosuppression regimens: Conversion, minimization, withdrawal, and avoidance. Am J Kidney Dis 2006; 47(4 Suppl 2): S37S51.
  • 5
    Cecka JM. The UNOS Scientific Renal Transplant Registry: 10 years of kidney transplants. Clin Transpl 1997: 114.
  • 6
    Billingham RE, Brent, L., Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953; 172: 603606.
  • 7
    Slavin, S, Strober, S, Fuks, Z, Kaplan HS. Long-term survival of skin allografts in mice treated with fractionated total lymphoid irradiation. Science 1976; 193: 12521254.
  • 8
    Slavin, S, Strober, S, Fuks, Z, Kaplan HS. Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: Long-term survival of allogeneic bone marrow and skin grafts. J Exp Med 1977; 146: 3448.
  • 9
    Ildstad ST, Wren SM, Bluestone JA, Barbieri SA, Stephany, D., Sachs DH. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2—-B10). J Immunol 1986; 136: 2833.
  • 10
    Sharabi, Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 1989; 169: 493502.
  • 11
    Tomita, Y, Khan, A, Sykes, M. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J Immunol 1994; 153: 10871098.
  • 12
    Higuchi, M, Zeng, D, Shizuru, J, et al. Immune tolerance to combined organ and bone marrow transplants after fractionated lymphoid irradiation involves regulatory NK T cells and clonal deletion. J Immunol 2002; 169: 55645570.
  • 13
    Strober, S, Modry DL, Hoppe RT, et al. Induction of specific unresponsiveness to heart allografts in mongrel dogs treated with total lymphoid irradiation and antithymocyte globulin. J Immunol 1984; 132: 10131018.
  • 14
    Huang CA, Fuchimoto, Y, Scheier-Dolberg, R, Murphy MC, Neville DM, Jr., Sachs DH. Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model. J Clin Invest 2000; 105: 173181.
  • 15
    Kawai, T., Cosimi AB, Colvin RB, et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 1995; 59: 256262.
  • 16
    Millan MT, Shizuru JA, Hoffmann, P, et al. Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. Transplantation 2002; 73: 13861391.
  • 17
    Fudaba, Y, Spitzer TR, Shaffer, J, et al. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: In vivo and in vitro analyses. Am J Transplant 2006; 6: 21212133.
  • 18
    Kawai, T., Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008; 358: 353361.
  • 19
    Scandling JD, Busque, S, Dejbakhsh-Jones, S, et al. Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med 2008; 358: 362368.
  • 20
    Lowsky, R, Takahashi, T, Liu YP, et al. Protective conditioning for acute graft-versus-host disease. N Engl J Med 2005; 353: 13211331.
  • 21
    Kohrt HE, Turnbull BB, Heydari, K, et al. TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors. Blood 2009; 114: 10991109.
  • 22
    Scandling JD, Busque, S, Shizuru JA, Engleman EG, Strober, S. Complete withdrawal of immunosuppressive drugs without rejection after kidney and hematopoietic cell transplantation. N Engl J Med 2011; 365: 13591360.
  • 23
    Takahashi, T, Dejbakhsh-Jones, S, Strober, S. Expression of CD161 (NKR-P1A) defines subsets of human CD4 and CD8 T cells with different functional activities. J Immunol 2006; 176: 211216.
  • 24
    Mehta-Damani, A, Markowicz, S, Engleman EG. Generation of antigen-specific CD8+ CTLs from naive precursors. J Immunol 1994; 153: 9961003.
  • 25
    Lan, F, Zeng, D, Huie, P, Higgins JP, Strober, S. Allogeneic bone marrow cells that facilitate complete chimerism and eliminate tumor cells express both CD8 and T-cell antigen receptor-alphabeta. Blood 2001; 97: 34583465.
  • 26
    Baron, F, Baker JE, Storb, R, et al. Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood 2004; 104: 22542262.
  • 27
    Nador RG, Hongo, D, Baker, J, Yao, Z, Strober, S. The changed balance of regulatory and naive T cells promotes tolerance after TLI and anti-T-cell antibody conditioning. Am J Transplant 2010; 10: 262272.
  • 28
    Hongo D, Tang X, Dutt S, Nador RG, Strober S. Interactions between NKT Cells and Tregs are required for tolerance to combined bone marrow and organ transplants. Blood 2012; 119: 15811589.